Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT04892277

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

NCT04935684

Conditions: Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
Locations: Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France

Service Maladies du sang CHU Angers Angers, France

Hématologie clinique CHU Besançon Besançon, France

Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France

View all 20 locations

View Trial Details

Recruiting

CAYA Cancer Prospective Cohort Study

NCT07632014

Conditions: Acute Lymphoblastic Leukemia (ALL), Cancer, Hematologic Diseases, +12 more
Locations: Yeolyan Center for Cancer and Blood Disorders Yerevan, Armenia

The Children's Cancer Hospital Egypt 57357 Cairo, Egypt

Unidad Nacional de Oncología Pediátrica (UNOP) Guatemala City, Guatemala

View Trial Details

Recruiting

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT06308588

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Montefiore Einstein Comprehensive Cancer Center The Bronx, New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

NCT05092451

Conditions: Acute Myeloid Leukemia (AML), B-cell Lymphoma, Blastic Transformation of Chronic Myeloid Leukemia, +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

NCT06236724

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NCT06697184

Conditions: CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States

The University of Kansas Cancer Center Westwood, Kansas, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View all 17 locations

View Trial Details

Recruiting

Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

NCT03586609

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

NCT05360160

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

NCT05405387

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Leukemia

Leukemia trial results

Related conditions